Annual Short Term Debt
$537.00 K
-$5.92 M-91.69%
December 31, 2023
Summary
- As of February 8, 2025, AVTX annual short term debt is $537.00 thousand, with the most recent change of -$5.92 million (-91.69%) on December 31, 2023.
- During the last 3 years, AVTX annual short term debt has risen by +$111.00 thousand (+26.06%).
- AVTX annual short term debt is now -91.69% below its all-time high of $6.46 million, reached on December 31, 2022.
Performance
AVTX Short Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Short Term Debt
$550.00 K
+$2000.00+0.36%
September 30, 2024
Summary
- As of February 8, 2025, AVTX quarterly short term debt is $550.00 thousand, with the most recent change of +$2000.00 (+0.36%) on September 30, 2024.
- Over the past year, AVTX quarterly short term debt has increased by +$2000.00 (+0.36%).
- AVTX quarterly short term debt is now -96.25% below its all-time high of $14.65 million, reached on June 30, 2023.
Performance
AVTX Quarterly Short Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Short Term Debt Formula
Short-Term Debt = Current Portion of Long-Term Debt + Short-Term Loans + Commercial Paper + Other Short-Term Borrowings
AVTX Short Term Debt Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -91.7% | +0.4% |
| 3 y3 years | +26.1% | -91.5% |
| 5 y5 years | - | -47.6% |
AVTX Short Term Debt Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -91.7% | +10.7% | -96.3% | +13.4% |
| 5 y | 5-year | -91.7% | +244.7% | -96.3% | +253.0% |
| alltime | all time | -91.7% | +244.7% | -96.3% | +253.0% |
Avalo Therapeutics Short Term Debt History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $550.00 K(+0.4%) |
| Jun 2024 | - | $548.00 K(+0.6%) |
| Mar 2024 | - | $545.00 K(+1.5%) |
| Dec 2023 | $537.00 K(-91.7%) | $537.00 K(+0.2%) |
| Sep 2023 | - | $536.00 K(-96.3%) |
| Jun 2023 | - | $14.65 M(+49.0%) |
| Mar 2023 | - | $9.83 M(+52.1%) |
| Dec 2022 | $6.46 M(+1232.4%) | $6.46 M(+109.1%) |
| Sep 2022 | - | $3.09 M(+489.7%) |
| Jun 2022 | - | $524.00 K(+0.4%) |
| Mar 2022 | - | $522.00 K(+7.6%) |
| Dec 2021 | $485.00 K(+13.8%) | $485.00 K(+121.5%) |
| Sep 2021 | - | $219.00 K(-24.0%) |
| Jun 2021 | - | $288.00 K(-19.3%) |
| Mar 2021 | - | $357.00 K(-16.2%) |
| Dec 2020 | $426.00 K(+173.4%) | $426.00 K(-5.1%) |
| Sep 2020 | - | $448.70 K(+4.0%) |
| Jun 2020 | - | $431.50 K(+177.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2019 | $155.80 K(-93.4%) | $155.80 K(-85.2%) |
| Sep 2019 | - | $1.05 M(0.0%) |
| Jun 2019 | - | $1.05 M(0.0%) |
| Mar 2019 | - | $1.05 M(0.0%) |
| Sep 2018 | - | $1.05 M(0.0%) |
| Jun 2018 | - | $1.05 M(+33.3%) |
| Mar 2018 | - | $787.50 K(+29.6%) |
| Jun 2017 | - | $607.60 K(-59.3%) |
| Mar 2017 | - | $1.49 M(-36.6%) |
| Dec 2016 | $2.35 M(-26.6%) | $2.35 M(-26.2%) |
| Sep 2016 | - | $3.19 M(-5.9%) |
| Jun 2016 | - | $3.39 M(+2.6%) |
| Mar 2016 | - | $3.30 M(+3.0%) |
| Dec 2015 | $3.21 M(+68.3%) | $3.21 M(+2.5%) |
| Sep 2015 | - | $3.13 M(+2.8%) |
| Jun 2015 | - | $3.04 M(+11.5%) |
| Mar 2015 | - | $2.73 M(+43.2%) |
| Dec 2014 | $1.91 M | $1.91 M |
FAQ
- What is Avalo Therapeutics annual short term debt?
- What is the all time high annual short term debt for Avalo Therapeutics?
- What is Avalo Therapeutics annual short term debt year-on-year change?
- What is Avalo Therapeutics quarterly short term debt?
- What is the all time high quarterly short term debt for Avalo Therapeutics?
- What is Avalo Therapeutics quarterly short term debt year-on-year change?
What is Avalo Therapeutics annual short term debt?
The current annual short term debt of AVTX is $537.00 K
What is the all time high annual short term debt for Avalo Therapeutics?
Avalo Therapeutics all-time high annual short term debt is $6.46 M
What is Avalo Therapeutics annual short term debt year-on-year change?
Over the past year, AVTX annual short term debt has changed by -$5.92 M (-91.69%)
What is Avalo Therapeutics quarterly short term debt?
The current quarterly short term debt of AVTX is $550.00 K
What is the all time high quarterly short term debt for Avalo Therapeutics?
Avalo Therapeutics all-time high quarterly short term debt is $14.65 M
What is Avalo Therapeutics quarterly short term debt year-on-year change?
Over the past year, AVTX quarterly short term debt has changed by +$2000.00 (+0.36%)